Stryker Corp
SYK374.555USD
+0.634+0.17%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
142.86BCap. mercado
47.73P/E TTM
Más Datos de Stryker Corp Compañía
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Información de la empresa
Código de la empresaSYK
Nombre de la empresaStryker Corp
Fecha de salida a bolsaMar 17, 1980
Fundada en1946
Director ejecutivoMr. Kevin A. Lobo
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección1941 Stryker Way
CiudadPORTAGE
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal49002
Teléfono12693852600
Sitio Webhttps://www.stryker.com/
Código de la empresaSYK
Fecha de salida a bolsaMar 17, 1980
Fundada en1946
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.34K
-52.57%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Allan C. Golston, CPA
Mr. Allan C. Golston, CPA
Independent Director
Independent Director
14.24K
+14.74%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
13.19K
+42.64%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
10.38K
+50.92%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
7.25K
--
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
5.82K
+0.90%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.21K
+1.01%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.34K
-52.57%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Allan C. Golston, CPA
Mr. Allan C. Golston, CPA
Independent Director
Independent Director
14.24K
+14.74%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
13.19K
+42.64%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Medical
3.85B
17.05%
Trauma and Extremities
3.51B
15.52%
Endoscopy
3.39B
15.00%
Instruments
2.83B
12.54%
Knees
2.45B
10.83%
Other
6.57B
29.06%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
16.94B
74.99%
Europe & Middle East & Africa (EMEA) (Region)
2.90B
12.82%
Asia Pacific (Region)
2.02B
8.94%
Other countries
735.00M
3.25%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Medical
3.85B
17.05%
Trauma and Extremities
3.51B
15.52%
Endoscopy
3.39B
15.00%
Instruments
2.83B
12.54%
Knees
2.45B
10.83%
Other
6.57B
29.06%
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.53%
Brown (John W)
5.25%
Greenleaf Trust
4.48%
BlackRock Institutional Trust Company, N.A.
4.34%
State Street Global Advisors (US)
3.87%
Other
73.52%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.53%
Brown (John W)
5.25%
Greenleaf Trust
4.48%
BlackRock Institutional Trust Company, N.A.
4.34%
State Street Global Advisors (US)
3.87%
Other
73.52%
Tipo
Accionista
Proporción
Investment Advisor
35.96%
Investment Advisor/Hedge Fund
29.85%
Bank and Trust
6.62%
Individual Investor
5.37%
Research Firm
2.92%
Pension Fund
1.98%
Sovereign Wealth Fund
1.34%
Hedge Fund
0.86%
Foundation
0.18%
Other
14.93%
Participación institucional
Hora de actualización: jue., 20 de feb
Hora de actualización: jue., 20 de feb
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
3383
326.28M
85.48%
-4.42M
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
2023Q3
2938
324.92M
85.54%
+14.80M
2023Q2
2898
325.04M
85.60%
+10.05M
2023Q1
2838
330.33M
87.03%
+17.40M
2022Q4
2800
311.07M
82.21%
-3.07M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
32.55M
8.53%
+257.04K
+0.80%
Dec 31, 2024
Brown (John W)
20.06M
5.25%
--
--
Feb 28, 2025
Greenleaf Trust
17.39M
4.56%
-355.66K
-2.00%
Feb 28, 2025
BlackRock Institutional Trust Company, N.A.
16.58M
4.34%
-688.56K
-3.99%
Dec 31, 2024
State Street Global Advisors (US)
14.78M
3.87%
+196.16K
+1.35%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.61M
2.78%
+48.98K
+0.46%
Dec 31, 2024
Wellington Management Company, LLP
8.38M
2.19%
-1.72M
-17.01%
Dec 31, 2024
Fidelity Management & Research Company LLC
7.37M
1.93%
+749.68K
+11.32%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.07M
1.85%
+168.44K
+2.44%
Dec 31, 2024
Capital Research Global Investors
6.84M
1.79%
-210.56K
-2.99%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Jensen Quality Growth ETF
6.4%
Parnassus Core Select ETF
4.69%
iShares U.S. Medical Devices ETF
4.18%
AdvisorShares Focused Equity ETF
4.05%
Gabelli Growth Innovators ETF
3.41%
Democratic Large Cap Core ETF
3.32%
JPMorgan Healthcare Leaders ETF
3.22%
Indexperts Quality Earnings Focused ETF
3.11%
Global X Aging Population ETF
2.92%
Tema Neuroscience and Mental Health ETF
2.76%
Ver más
Jensen Quality Growth ETF
Proporción6.4%
Parnassus Core Select ETF
Proporción4.69%
iShares U.S. Medical Devices ETF
Proporción4.18%
AdvisorShares Focused Equity ETF
Proporción4.05%
Gabelli Growth Innovators ETF
Proporción3.41%
Democratic Large Cap Core ETF
Proporción3.32%
JPMorgan Healthcare Leaders ETF
Proporción3.22%
Indexperts Quality Earnings Focused ETF
Proporción3.11%
Global X Aging Population ETF
Proporción2.92%
Tema Neuroscience and Mental Health ETF
Proporción2.76%
Dividendos
Un total de
5.22B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 05, 2023
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 31, 2024
Dec 28, 2023
Aug 02, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 10, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 31, 2023
Jun 29, 2023
Feb 09, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Dec 07, 2022
SYK.NB Final Cash Dividend of gross USD 0.75 paid on Jan 31, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 31, 2023
Dec 29, 2022
Aug 03, 2022
SYK.NB Interim Cash Dividend of gross USD 0.695 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos